Announcements Trials
Browse Landscape

Status

Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 57Observational 2

Sponsor

Cancer Type

Genitourinary 3Gastrointestinal 2Breast 2Tumor-Agnostic 1Gynecologic 1Dermatologic 1

Conditions

Breast Neoplasms 2

Interventions

Surveys and Questionnaires 79Blood Specimen Collection 67palbociclib 40Trastuzumab 34Drug Therapy 30Letrozole 29Anastrozole 27Radiotherapy 26Immunohistochemistry 26Mastectomy, Segmental 22Amplified Fragment Length Polymorphism Analysis 22Fulvestrant 21Biopsy 21exemestane 20Tamoxifen 20Interviews as Topic 20Gene Expression Profiling 20Magnetic Resonance Spectroscopy 19ribociclib 18Specimen Handling 18Mastectomy 18Neoadjuvant Therapy 17Paclitaxel 16High-Energy Shock Waves 16Capecitabine 16trastuzumab deruxtecan 15Mammography 15Psychiatric Rehabilitation 14Polymerase Chain Reaction 13Observation 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Educational Status × Breast × Clear all
NCT04996316 2026-02-13

MammoScreen Breast Cancer Risk Assessment and Decision Aid for Breast Cancer Screening and Referrals

OHSU Knight Cancer Institute

Enrolling by invitation
1,141 enrolled
Breast

Breast Neoplasms

NCT04817709 2021-05-24

Development of a Patient Decision Aid for Women Considering Breast Reconstruction

M.D. Anderson Cancer Center

Completed
126 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡